Femoral stenting trial pitches Cordis vs Bard
This article was originally published in Clinica
Executive Summary
A head-to-head, multicentre, peripheral artery disease trial is underway to compare Cordis' Smart Control nitinol stent with Bard Peripheral Vascular's Luminexx 6F vascular stent in superficial femoral artery stenosis.